Iovance Biotherapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Sep 2007 | — | $8.0K | $0 |
| Dec 2007 | — | — | $0 |
| Dec 2007 | — | $61.0K | — |
| Dec 2008 | — | $2.3K | $2.9K |
| Dec 2009 | — | $-13.5K | $8.3K |
| Jun 2010 | — | — | $209.3K |
| Sep 2010 | — | — | $795.9K |
| Dec 2010 | — | $638.1K | $1.3M |
| Mar 2011 | — | — | $723.0K |
| Jun 2011 | — | $-1.4M | $268.6K |
| Sep 2011 | — | $-5.7M | $128.4K |
| Dec 2011 | — | $-12.8M | $510.2K |
| Mar 2012 | — | $-17.3M | $0 |
| Jun 2012 | — | $-16.6M | $15.5K |
| Sep 2012 | — | $-16.6M | $0 |
| Dec 2012 | — | $-11.3M | $0 |
| Mar 2013 | — | $-12.3M | $0 |
| Jun 2013 | — | $-2.8M | $569.6K |
| Sep 2013 | — | $-3.3M | $129.8K |
| Dec 2013 | — | $17.6M | $19.7M |
| Mar 2014 | — | $16.8M | $17.9M |
| Jun 2014 | — | $17.4M | $18.4M |
| Sep 2014 | — | $16.2M | $17.2M |
| Dec 2014 | — | $44.8M | $44.9M |
| Mar 2015 | — | $111.6M | $111.3M |
| Jun 2015 | — | $112.9M | $12.6M |
| Sep 2015 | — | $109.4M | $30.8M |
| Dec 2015 | — | $104.0M | $33.6M |
| Mar 2016 | — | $98.9M | $38.9M |
| Jun 2016 | — | $188.9M | $121.0M |
| Sep 2016 | — | $179.1M | $92.9M |
| Dec 2016 | — | $166.9M | $106.7M |
| Mar 2017 | — | $149.9M | $107.1M |
| Jun 2017 | — | $129.2M | $114.3M |
| Sep 2017 | — | $165.4M | $163.4M |
| Dec 2017 | — | $145.5M | $145.4M |
| Mar 2018 | — | $292.6M | $297.1M |
| Jun 2018 | — | $270.6M | $246.0M |
| Sep 2018 | — | $254.2M | $80.7M |
| Dec 2018 | — | $466.2M | $82.2M |
| Mar 2019 | — | $434.9M | $54.1M |
| Jun 2019 | — | $397.4M | $76.9M |
| Sep 2019 | — | $355.1M | $38.9M |
| Dec 2019 | — | $299.0M | $14.0M |
| Mar 2020 | — | $243.3M | $52.5M |
| Jun 2020 | — | $758.3M | $160.6M |
| Sep 2020 | — | $711.8M | $68.3M |
| Dec 2020 | — | $656.5M | $67.3M |
| Mar 2021 | — | $647.4M | $132.0M |
| Jun 2021 | — | $744.4M | $82.8M |
| Sep 2021 | — | $698.3M | $58.6M |
| Dec 2021 | — | $621.7M | $78.2M |
| Mar 2022 | — | $552.0M | $92.4M |
| Jun 2022 | — | $472.7M | $108.1M |
| Sep 2022 | — | $393.7M | $118.4M |
| Dec 2022 | — | $499.6M | $231.7M |
| Mar 2023 | — | $666.9M | $543.5M |
| Jun 2023 | — | $578.6M | $230.0M |
| Sep 2023 | — | $674.0M | $267.7M |
| Dec 2023 | — | $584.6M | $114.9M |
| Mar 2024 | — | $680.0M | $134.2M |
| Jun 2024 | — | $768.5M | $228.7M |
| Sep 2024 | — | $773.5M | $164.2M |
| Dec 2024 | — | $710.4M | $115.7M |
| Mar 2025 | — | $767.9M | $171.7M |
| Jun 2025 | — | $698.5M | $132.5M |
| Sep 2025 | — | $702.3M | $158.1M |
| Dec 2025 | — | $698.6M | $163.1M |
| Mar 2026 | — | $721.8M | $196.5M |
| Jun 2026 | — | $736.0M | $110.8M |